Marcus Hollenbach1, Jürgen Feisthammel2, Albrecht Hoffmeister2. 1. Bereich Gastroenterologie, Klinik für Onkologie, Gastroenterologie, Hepatologie, Pneumologie und Infektiologie, Department für Innere Medizin, Neurologie und Dermatologie, Universitätsklinikum Leipzig AöR, Liebigstr. 20, 04103, Leipzig, Deutschland. marcus.hollenbach@medizin.uni-leipzig.de. 2. Bereich Gastroenterologie, Klinik für Onkologie, Gastroenterologie, Hepatologie, Pneumologie und Infektiologie, Department für Innere Medizin, Neurologie und Dermatologie, Universitätsklinikum Leipzig AöR, Liebigstr. 20, 04103, Leipzig, Deutschland.
Abstract
BACKGROUND: Acute pancreatitis (AP) represents a frequent gastrointestinal diseases. Approximately 80% of patients have a mild course of the disease and conservative treatment is sufficient; however, 20% of patients develop a severe AP with local and systemic complications. This article focuses on the currently recommended endoscopic management of severe AP. OBJECTIVE: Classification of AP by the revised Atlanta classification and the occurrence of local or systemic complications. Summary of current evidence with respect to endoscopic management. MATERIAL AND METHODS: Inspection of the current literature from specialist journals and current guidelines. RESULTS: The AP is classified as mild, moderate or severe based on systemic (hypotension, renal failure, lung failure) and/or local complications, such as acute peripancreatic fluid collections (APFC), peripancreatic pseudocysts (PPC), acute necrotic collections (ANC) and walled-off necrosis (WON). In recent years the staged endoscopic treatment of infected ANC, WON and PPC has become established. The initial step is the endoscopic ultrasound-guided puncture and drainage with plastic or lumen-apposing metal stents. For solid components or insufficient drainage, a transgastric endoscopic necrosectomy is recommended. The treatment of severe AP requires an interdisciplinary management in specialized centers and regular re-evaluation of the therapeutic efficacy. CONCLUSION: Interventional endoscopy has become established as the standard for treatment of severe AP.
BACKGROUND: Acute pancreatitis (AP) represents a frequent gastrointestinal diseases. Approximately 80% of patients have a mild course of the disease and conservative treatment is sufficient; however, 20% of patients develop a severe AP with local and systemic complications. This article focuses on the currently recommended endoscopic management of severe AP. OBJECTIVE: Classification of AP by the revised Atlanta classification and the occurrence of local or systemic complications. Summary of current evidence with respect to endoscopic management. MATERIAL AND METHODS: Inspection of the current literature from specialist journals and current guidelines. RESULTS: The AP is classified as mild, moderate or severe based on systemic (hypotension, renal failure, lung failure) and/or local complications, such as acute peripancreatic fluid collections (APFC), peripancreatic pseudocysts (PPC), acute necrotic collections (ANC) and walled-off necrosis (WON). In recent years the staged endoscopic treatment of infected ANC, WON and PPC has become established. The initial step is the endoscopic ultrasound-guided puncture and drainage with plastic or lumen-apposing metal stents. For solid components or insufficient drainage, a transgastric endoscopic necrosectomy is recommended. The treatment of severe AP requires an interdisciplinary management in specialized centers and regular re-evaluation of the therapeutic efficacy. CONCLUSION: Interventional endoscopy has become established as the standard for treatment of severe AP.
Authors: Nicolien J Schepers; Olaf J Bakker; Marc G Besselink; Usama Ahmed Ali; Thomas L Bollen; Hein G Gooszen; Hjalmar C van Santvoort; Marco J Bruno Journal: Gut Date: 2018-06-27 Impact factor: 23.059
Authors: E Patchen Dellinger; Christopher E Forsmark; Peter Layer; Philippe Lévy; Enrique Maraví-Poma; Maxim S Petrov; Tooru Shimosegawa; Ajith K Siriwardena; Generoso Uomo; David C Whitcomb; John A Windsor Journal: Ann Surg Date: 2012-12 Impact factor: 12.969
Authors: Julia Mayerle; Annegret Dummer; Mathias Sendler; Sudarshan Ravi Malla; Cindy van den Brandt; Steffen Teller; Ali Aghdassi; Claudia Nitsche; Markus M Lerch Journal: J Gastroenterol Hepatol Date: 2012-03 Impact factor: 4.029
Authors: Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege Journal: Gut Date: 2012-10-25 Impact factor: 23.059